Loading match intelligence
Resolves to Yes if a regulatory agency approves any gene therapy that targets a neurological disease (e.g., Alzheimer's, Parkinson's, spinal muscular atrophy) before the close date.
Resolves Yes if Resolves to Yes if a regulatory agency approves any gene therapy that targets a neurological disease (e.g., Alzheimer's, Parkinson's, spinal muscular atrophy) before the close date.
Outcome verified from fda.gov.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…